Royal Bank of Canada’s SQZ Biotechnologies Company SQZ Stock Holding History

Royal Bank of Canada’s Portfolio SQZ Stock Details SQZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-646	Closed	–	–	7962
2023 Q2	$0	Buy	+646	New	+$367	﹤0.01%	7909
2022 Q2	–	Sell	-1,398	Closed	-$7K	–	7967
2022 Q1	$7K	Sell	1,398 -3,321	-70%	-$21.1K	﹤0.01%	7153
2021 Q4	$42K	Buy	4,719 +1,660	+54%	+$20.3K	﹤0.01%	6472
2021 Q3	$44K	Buy	3,059 +1,500	+96%	+$20.3K	﹤0.01%	6239
2021 Q2	$23K	Buy	1,559 +863	+124%	+$11.3K	﹤0.01%	6503
2021 Q1	$10K	Buy	696 +403	+138%	+$8.19K	﹤0.01%	6823
2020 Q4	$8K	Buy	+293	New	+$7.48K	﹤0.01%	6498

Other funds holding SQZ

AIG

American International Group New York $609M AUM 23.67% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

BSB

Bangor Savings Bank Bangor, Maine $1.36B AUM 19.29% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Royal Bank of Canada's SQZ Position: Q3 2023 in Review

Royal Bank of Canada sold out of SQZ Biotechnologies Company (SQZ) in Q3 2023, closing a stake of 646 shares.

Royal Bank of Canada first reported a position in SQZ in Q4 2020 and held it in 7 quarters. The position peaked at $44K in Q3 2021. 5 funds tracked by Wall St. Rank hold SQZ as of Q3 2023.

Royal Bank of Canada reported no remaining SQZ Biotechnologies Company position as of Q3 2023 after selling out during the quarter.
Royal Bank of Canada sold 646 SQZ Biotechnologies Company shares in Q3 2023.
Royal Bank of Canada first reported a position in SQZ Biotechnologies Company in Q4 2020 and held it in 7 quarters.
Royal Bank of Canada's SQZ Biotechnologies Company position peaked at $44K in Q3 2021.
5 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q3 2023.

Based on Royal Bank of Canada's 13F filing for Q3 2023, filed 14 Nov 2023.